Analyst Comments
Provided by:
Set Up E-mail Alerts For Analyst Comments »
The top source for Wall Street analyst comments, price target and estimate changes, and speculation.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
-
Cantor Fitzgerald Reiterates Neutral Rating on Sarepta Therapeutics (SRPT)
-
Oracle (ORCL) PT Raised to $271 at Cantor Fitzgerald
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $290 at Cantor Fitzgerald
-
-
-
-
-
-
-
Goldman Sachs Downgrades IGO Limited (IGO:AU) (IPGDF) to Neutral
-
-
-
-
-
-
-
Goldman Sachs Reiterates Buy Rating on Pepsico (PEP)
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Ligand Pharma (LGND)
-
-
-
-
-
-
-
Visteon (VC) PT Raised to $124 at Guggenheim
-
-
-
-
-
-
-
Raymond James Upgrades Canadian National Railway (CNR:CN) (CNI) to Outperform
-
-
-
-
-
-
-
Stifel Comments on Taiwan Semi (TSM)
-
-
-
-
-
424,201 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst Comments reports.
